Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Radiation Safety Concerns Could Drive New Legislation, Quality Standards

This article was originally published in The Gray Sheet

Executive Summary

Before it decides on a legislative approach to address medical radiation safety, the Health Subcommittee of the House Energy and Commerce Committee will likely delve into the topic further, Subcommittee Chairman Frank Pallone, Jr., D-N.J., said during a Feb. 26 hearing

You may also be interested in...



Imaging Groups Worry CMS Is Preparing To Diminish Equipment Servicing Requirements

The American College of Radiology, the Society for Vascular Ultrasound and the Society of Diagnostic Medical Sonography voiced anxiety about possible changes to CMS standards for hospital equipment servicing in letters obtained by “The Gray Sheet.”

Technology Hazards Remain High, But Industry Can Help, ECRI Exec Says

The device industry should work more closely with hospitals, professional societies, FDA and others to combat the growing incidence of preventable medical errors that stem from the misuse of technologies, according to a non-profit hospital services group.

Technology Hazards Remain High, But Industry Can Help, ECRI Exec Says

The device industry should work more closely with hospitals, professional societies, FDA and others to combat the growing incidence of preventable medical errors that stem from the misuse of technologies, according to a non-profit hospital services group.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028589

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel